Illuminating New Pathways to Intervention
What makes EarGenie® different
EarGenie® is the first fNIRS device designed for clinical use in audiology clinics. EarGenie accurately and objectively assesses hearing and speech discrimination ability, supporting critical unmet needs in clinical practice:
-
Assessment of the functional hearing of babies with auditory neuropathy.
-
Objective programming of cochlear implants and validation of hearing device programs.
-
Evaluation, using our speech discrimination test, of whether an infant’s hearing aids are supporting language development, thus leading to earlier referral for cochlear implantation when appropriate.
-
Objective measurement of speech discrimination in children with language delay to help speech pathologists provide the most effective therapy.
EarGenie®:
-
Uses advanced algorithms with proven accuracy to analyze auditory responses rapidly and automatically
-
Is designed to be baby friendly and easy to use
-
Features an intuitive user interface for ease of clinical use
What we measure
EarGenie® uses functional near-infrared spectroscopy (fNIRS) to measure how well a baby or child can hear and distinguish between different speech sounds.
fNIRS is a non-invasive brain imaging technique using near-infrared light to measure brain activity. It works by measuring changes in the concentration of oxygenated and deoxygenated haemoglobin in the brain.
-
Light shines into the brain from light sources in the head gear and is partially absorbed by the haemoglobin in the blood.
-
Light returning from the brain is detected by light sensors.
-
Areas of the brain activated by sound will show changes in oxygenated and deoxygenated haemoglobin level.
-
Using our proprietary algorithms, we can accurately measure these haemoglobin changes.
_edited.png)
The brain's hearing and language centres are imaged